Behavioral Posology

Behavioral Posology: A Novel Paradigm for Modeling the Healthy ...

Behavioral posology is a modeling paradigm that can be used to analyze the effects of repeatable behaviors on mental wellbeing, and to determine ...

A Novel Paradigm for Modeling the Healthy Limits of Behaviors - OSF

The authors propose “behavioral posology” as a novel modeling paradigm for quantifying the healthy limits of behaviors through the concept of ...

A Novel Paradigm for Modeling the Healthy Limits of Behaviors

A behavioral frequency response analysis (BFRA) of the model demonstrates how behavior repetition may result in a hormetic dose–response ...

Behavioral Posology: A Novel Paradigm for Modeling the Healthy ...

The authors propose “behavioral posology” as a novel modeling paradigm for quantifying the healthy limits of behaviors through the concept of behavioral dose.

Behavioral Posology: A Novel Paradigm for Modeling the Healthy ...

The authors propose “behavioral posology” as a novel modeling paradigm for quantifying the healthy limits of behaviors through the concept of behavioral ...

Behavioral Posology: A Novel Paradigm for Modeling the Healthy ...

A behavioral frequency response analysis. (BFRA) of the model demonstrates how behavior repetition may result in a hormetic dose–response ...

A Novel Paradigm for Modeling the Healthy Limits of Behaviors - OSF

Description: This project contains the R code for the article "Behavioral Posology: A Novel Paradigm for Modeling the Healthy Limits of ...

Behavioral Posology: A Novel Paradigm for Modeling the Healthy ...

The authors propose “behavioral posology” as a novel modeling paradigm for quantifying the healthy limits of behaviors through the concept of behavioral dose.

Behavioral Posology: A Novel Paradigm for Modeling the Healthy ...

Dive into the research topics of 'Behavioral Posology: A Novel Paradigm for Modeling the Healthy Limits of Behaviors'. Together they form a unique fingerprint.

A Dose-Ranging Study of Behavioral and Pharmacological ...

Both behavioral and medication treatments produced highly significant and positive effects on children's behavior.

Approaches for Informing Optimal Dose of Behavioral Interventions

The purpose of this study is to present approaches to inform intervention duration, frequency, and amount

A dose-ranging study of behavioral and pharmacological treatment ...

Children concurrently received in random order placebo, 0.15 mg/kg/dose, 0.3 mg/kg/dose, or 0.6 mg/kg/dose MPH, 3 times daily with dose manipulated on a daily ...

What Is Behavioral Medicine? | SBM

Behavioral medicine is the interdisciplinary field concerned with the development and integration of behavioral, psychosocial, and biomedical science ...

Olanzapine (oral route) - Mayo Clinic

This medicine should not be used to treat behavioral problems in older adult patients who have dementia or Alzheimer's disease. ... dose and go ...

Behavioral medicine - Wikipedia

The practice of behavioral medicine encompasses health psychology, but also includes applied psychophysiological therapies such as biofeedback, hypnosis, and ...

Quviviq - accessdata.fda.gov

If. QUVIVIQ is taken in these circumstances, caution patients against driving and other activities requiring complete mental alertness. Co-administration with ...

Human Response to Repeated Low-Dose d-Amphetamine - Nature

We reported progressively greater behavioral responses to repeated d-amphetamine in human subjects that represented a potential model of behavioral ...

Effectiveness of High-dose Clonazepam Versus Low-Dose ...

Treatments for insomnia in older adult populations may include medication, cognitive behavioral therapy, relaxation techniques, and lifestyle modifications. As ...

Patient education: Parkinson disease treatment options

Impulsive behaviors, such as compulsive gambling or sexual behaviors, can also occur. Lowering of the levodopa dose or, if necessary, treatment ...

Behavioral Pharmacology Research Unit - Johns Hopkins Medicine

The Behavioral Pharmacology Research Unit (BPRU) at Johns Hopkins is a world leading site in the science of psychoactive drugs and behavior.